ACADIA Pharmaceuticals Inc banner

ACADIA Pharmaceuticals Inc
SWB:DR6

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
SWB:DR6
Watchlist
Price: 18.46 EUR -3%
Market Cap: €3B

Wall St Price Targets

DR6 Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast DR6 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DR6 is 27 EUR with a low forecast of 14.32 EUR and a high forecast of 39.41 EUR.

Lowest Forecast
Price Target
14.32 EUR
22% Downside
Average Forecast
Price Target
27 EUR
46% Upside
Highest Forecast
Price Target
39.41 EUR
113% Upside
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
CALM
Cal-Maine Foods Inc
16% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-8% Downside

Revenue
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 8 years is 9%.

Operating Income
Forecast

N/A
Past Growth
27% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
27% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Operating Income over the next 8 years is 27%.

Net Income
Forecast

N/A
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 8 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DR6's stock price target?
Price Target
27 EUR

According to Wall Street analysts, the average 1-year price target for DR6 is 27 EUR with a low forecast of 14.32 EUR and a high forecast of 39.41 EUR.

What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%

The compound annual growth rate for Revenue over the next 8 years is 9%.

What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%

The compound annual growth rate for Operating Income over the next 8 years is 27%.

What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
11%

The compound annual growth rate for Net Income over the next 8 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett